Overview Fundamentals API Earnings EOD API Sample Code Pricing

Biomea Fusion Inc (BMEA NASDAQ) stock market data APIs

$5.59 0.05(0.9%) as of July 26, 2024
Price chart is built with Anychart

Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, a covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes. The company was incorporated in 2017 and is headquartered in Redwood City, California.

Biomea Fusion Inc Financial Data Overview

5.54
5.59
-
5.63
5.33
3.61-23.03
202 M
35 945 K
0
-1.09
-0.545
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'BMEA',
Type: 'Common Stock',
Name: 'Biomea Fusion Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00YS4WDC9',
ISIN: NULL,
CUSIP: NULL,
CIK: '1840439',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-04-16',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Biomea Fusion Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -135 520 992
  • Earnings Per Share -3.55
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Biomea Fusion Inc Earnings via APIs

  • Latest Release 2024-05-02
  • EPS/Forecast -0.99

Get Biomea Fusion Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com